giredestrant,sacituzumab
roche,Gilead
['breast', 'giredestrant']
#asco23 | hall a | sunday 8am ct
lidera breast cancer (bc): phase iii adjuvant study of giredestrant vs. physician s choice of endocrine therapy (pcet) in patients (pts) with estrogen receptor-positive, her2-negative early bc (er+, her2 ebc) #mgccatasco23
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.